NACHT MARIUS 13D and 13G filings for BiondVax Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-27 09:04 am Purchase | 2022-12-20 | 13D | BIONDVAX PHARMACEUTICALS LTD. BVXV | NACHT MARIUS | 170,961,770 12.300% | 153,865,593 (+900.00%) | Filing |
| 2022-01-11 12:47 pm Unchanged | 2021-12-29 | 13D | BIONDVAX PHARMACEUTICALS LTD. BVXV | NACHT MARIUS | 17,096,177 23.600% | 0 (Unchanged) | Filing |